跳至主要内容
临床试验/NCT02855281
NCT02855281已完成不适用

Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer

Wissenschaftliches Institut Bethanien e.V1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
PD-L1 Detection in Pleural Effusion Based on All Cases With Successful PD-L1 Analysis

研究概览

简要总结

This is a prospective diagnostic pilot study to create hypotheses regarding immunocytochemistry (ICC) PD-L1 analysis of pleural effusions in NSCLC patients as compared to the reference standard of PD-L1 immunohistochemistry (IHC). This comparison will be done to assess sensitivity and specificity of PD-L1 detection by ICC in pleural effusions.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Presence of malignant pleural effusion with indication for pleural puncture and thoracoscopy
  • Confirmed diagnosis of non-small cell lung cancer according to ERS guidelines
  • Written informed consent

排除标准

  • Pregnancy and/or lactation
  • Acute and life-threatening illness (instable angina pectoris, acute pulmonary arterial embolism, myocardial infarction, etc.)
  • Any contraindication to undergo thoracoscopy (e.g. anticoagulation therapy which cannot be discontinued for the procedure)
  • Any medical, psychological or other condition impairing the patient's ability to provide informed consent

结局指标

主要结局

PD-L1 Detection in Pleural Effusion Based on All Cases With Successful PD-L1 Analysis

时间窗: At baseline

Based on all cases where PD-L1 analysis was indicated and sucessful (i.e. giving definite results), the immunocytochemistry analysis of PE was compared with the immunohistochemistry analysis of pleural tissue.Two different alternatives were calculated: * PD-L1 expression with a TPS ≥50% was defined as PD-L1-positive. * PD-L1 expression with a TPS ≥1% was defined as PD-L1-positive.

PD-L1 Prevalence IHC

时间窗: At baseline

Number/prevalence of PD-L1-positive patients according to immunohistochemistry (IHC) of pleural biopsy.

PD-L1 Prevalence ICC

时间窗: At baseline

Number/prevalence of PD-L1-positive patients according to immunocytochemistry (ICC) of pleural aspirate

次要结局

  • Tumor Cell Detection in Pleural Effusion(At baseline)
  • PD-L1 Detection in Pleural Effusion Based on All Cases With Indication for PD-L1 Analysis(At baseline)

研究者

发起方
Wissenschaftliches Institut Bethanien e.V
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验